Published in Proc Natl Acad Sci U S A on November 01, 1990
Adenoviruses in the immunocompromised host. Clin Microbiol Rev (1992) 3.56
Human immunodeficiency virus vectors for inducible expression of foreign genes. J Virol (1992) 2.70
HIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic intervention. Retrovirology (2011) 1.17
Selective killing of CD4+ cells harboring a human immunodeficiency virus-inducible suicide gene prevents viral spread in an infected cell population. Proc Natl Acad Sci U S A (1992) 1.09
Gene therapy: progress and predictions. Proc Biol Sci (2015) 0.94
Specific ablation of human immunodeficiency virus Tat-expressing cells by conditionally toxic retroviruses. Proc Natl Acad Sci U S A (1994) 0.81
Activation of HIV-1-specific immune responses to an HIV-1 vaccine constructed from a replication-defective adenovirus vector using various combinations of immunization protocols. Clin Exp Immunol (2001) 0.80
Targeting gene expression of the mouse uroplakin II promoter to human bladder cells. Urol Res (2003) 0.77
Expression of Herpes Simplex Virus Thymidine Kinase/Ganciclovir by RNA Trans-Splicing Induces Selective Killing of HIV-Producing Cells. Mol Ther Nucleic Acids (2017) 0.75
Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science (1983) 43.61
Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol (1977) 41.93
Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science (1984) 33.32
Mapping of RNA by a modification of the Berk-Sharp procedure: the 5' termini of 15 S beta-globin mRNA precursor and mature 10 s beta-globin mRNA have identical map coordinates. Nucleic Acids Res (1979) 31.23
The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature (1989) 13.92
Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc Natl Acad Sci U S A (1977) 11.20
The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science (1988) 11.05
Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells. Cell (1979) 10.95
Regulation by HIV Rev depends upon recognition of splice sites. Cell (1989) 7.13
Long-term cultures of HTLV-III--infected T cells: a model of cytopathology of T-cell depletion in AIDS. Science (1986) 5.86
Resolving the functions of overlapping viral genes by site-specific mutagenesis at a mRNA splice site. Nature (1982) 5.61
Regulatory pathways governing HIV-1 replication. Cell (1989) 4.97
Alternative mechanisms for activation of human immunodeficiency virus enhancer in T cells. Science (1988) 4.16
HIV TAR: an RNA enhancer? Cell (1989) 2.74
Selective killing of HIV-infected cells by recombinant human CD4-Pseudomonas exotoxin hybrid protein. Nature (1988) 2.55
Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1. Proc Natl Acad Sci U S A (1983) 2.54
Replication and pathogenesis of the AIDS virus. J Acquir Immune Defic Syndr (1988) 2.50
HIV-1 production from infected peripheral blood T cells after HTLV-I induced mitogenic stimulation. Science (1988) 2.37
Two cis-acting elements responsible for posttranscriptional trans-regulation of gene expression of human T-cell leukemia virus type I. Proc Natl Acad Sci U S A (1988) 2.25
Identification of sequences in the herpes simplex virus thymidine kinase gene required for efficient processing and polyadenylation. Mol Cell Biol (1985) 1.79
Targeting of an inducible toxic phenotype in animal cells. Proc Natl Acad Sci U S A (1988) 1.78
Thymidine kinase obliteration: creation of transgenic mice with controlled immune deficiency. Proc Natl Acad Sci U S A (1989) 1.74
Group C adenovirus DNA sequences in human lymphoid cells. J Virol (1986) 1.47
Inhibition of cellular alpha and virally induced deoxyribonucleic acid polymerases by the triphosphate of acyclovir. Antimicrob Agents Chemother (1980) 1.41
HIV-infected cells are killed by rCD4-ricin A chain. Science (1988) 1.37
Trans-activation of the human immunodeficiency virus long terminal repeat sequences, expressed in an adenovirus vector, by the adenovirus E1A 13S protein. Proc Natl Acad Sci U S A (1988) 1.34
Nonpermissivity of human peripheral blood lymphocytes to adenovirus type 2 infection. J Virol (1988) 1.31
Productive infection of cultured human lymphoid cells by adenovirus. J Virol (1987) 1.17
Method for introducing site-specific mutations into adenovirus 2 genome: construction of a small deletion mutant in VA-RNAI gene. Proc Natl Acad Sci U S A (1981) 0.87
Complications of gamma knife surgery for Parkinson disease. Arch Neurol (2001) 3.97
Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins. Cell (1994) 3.86
A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. EMBO J (1995) 3.70
Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation. Proc Natl Acad Sci U S A (1995) 3.28
Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene (1995) 2.89
Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis. Nucleic Acids Res (1989) 2.72
Physical mapping of a large-plaque mutation of adenovirus type 2. J Virol (1979) 2.50
Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein. Proc Natl Acad Sci U S A (1991) 2.17
BH3-only proteins in apoptosis and beyond: an overview. Oncogene (2008) 2.13
Identification of a cellular protein that specifically interacts with the essential cysteine region of the HIV-1 Tat transactivator. Virology (1996) 2.12
Interaction between a cellular protein that binds to the C-terminal region of adenovirus E1A (CtBP) and a novel cellular protein is disrupted by E1A through a conserved PLDLS motif. J Biol Chem (1998) 2.06
Adenovirus 2 Ip+ locus codes for a 19 kd tumor antigen that plays an essential role in cell transformation. Cell (1983) 2.01
Adenovirus E1B-19K/BCL-2 interacting protein BNIP3 contains a BH3 domain and a mitochondrial targeting sequence. J Biol Chem (1998) 1.81
Distinct cis-acting regions in U3 regulate trans-activation of the human spumaretrovirus long terminal repeat by the viral bel1 gene product. Nucleic Acids Res (1991) 1.63
Binding of CtIP to the BRCT repeats of BRCA1 involved in the transcription regulation of p21 is disrupted upon DNA damage. J Biol Chem (1999) 1.57
Painful diffuse osteosclerosis after intravenous drug abuse. Am J Med (1992) 1.56
Role of the PLDLS-binding cleft region of CtBP1 in recruitment of core and auxiliary components of the corepressor complex. Mol Cell Biol (2007) 1.49
Mutants in a conserved region near the carboxy-terminus of HIV-1 Rev identify functionally important residues and exhibit a dominant negative phenotype. Virology (1990) 1.48
19-kDa tumor antigen coded by early region E1b of adenovirus 2 is required for efficient synthesis and for protection of viral DNA. J Biol Chem (1984) 1.47
A unique pattern of integrated viral genes in hamster cells transformed by highly oncogenic human adenovirus 12. Cell (1976) 1.45
Enhanced isolation of respiratory syncytial virus in cell culture. J Clin Microbiol (1986) 1.44
Epstein-Barr virus BHRF1 protein protects against cell death induced by DNA-damaging agents and heterologous viral infection. Virology (1994) 1.42
An N-terminal region of adenovirus E1a essential for cell transformation and induction of an epithelial cell growth factor. Oncogene (1988) 1.41
Enhanced infectivity of adenovirus type 2 DNA and a DNA-protein complex. J Virol (1978) 1.40
Enhanced ras oncogene mediated cell transformation and tumorigenesis by adenovirus 2 mutants lacking the C-terminal region of E1a protein. Oncogene (1989) 1.40
Nicotinamide adenine dinucleotide stimulates oligomerization, interaction with adenovirus E1A and an intrinsic dehydrogenase activity of CtBP. FEBS Lett (2003) 1.38
Comparison of MPTP-induced changes in spontaneous neuronal discharge in the internal pallidal segment and in the substantia nigra pars reticulata in primates. Exp Brain Res (1999) 1.35
The CtBP binding domain in the adenovirus E1A protein controls CR1-dependent transactivation. Nucleic Acids Res (1996) 1.33
Simplified method for typing herpes simplex virus by restriction endonuclease analysis. J Clin Microbiol (1983) 1.32
Adenovirus transforming 19-kD T antigen has an enhancer-dependent trans-activation function and relieves enhancer repression mediated by viral and cellular genes. Genes Dev (1987) 1.30
Evidence that a second tumor antigen coded by adenovirus early gene region E1a is required for efficient cell transformation. Proc Natl Acad Sci U S A (1985) 1.27
Strategy for efficient detection of respiratory viruses in pediatric clinical specimens. Diagn Microbiol Infect Dis (1986) 1.25
Evaluation of two immunofluorescence assays with monoclonal antibodies for typing of herpes simplex virus. J Clin Microbiol (1985) 1.25
Synergistic activation of the human immunodeficiency virus type 1 promoter by the viral Tat protein and cellular transcription factor Sp1. J Virol (1992) 1.25
Relationship between the transforming and transcriptional regulatory functions of adenovirus 2 E1a oncogene. Virology (1987) 1.24
Heterologous basic domain substitutions in the HIV-1 Tat protein reveal an arginine-rich motif required for transactivation. EMBO J (1991) 1.24
Functional dissection of the human spumaretrovirus transactivator identifies distinct classes of dominant-negative mutants. J Virol (1993) 1.24
p53-independent apoptotic and necrotic cell deaths induced by adenovirus infection: suppression by E1B 19K and Bcl-2 proteins. Cell Growth Differ (1995) 1.23
BH3-only protein BIK induces caspase-independent cell death with autophagic features in Bcl-2 null cells. Oncogene (2007) 1.22
Pre-early polypeptides of bacteriophages T5 and BF23. J Virol (1977) 1.21
Acetylation by p300 regulates nuclear localization and function of the transcriptional corepressor CtBP2. J Biol Chem (2005) 1.17
Functional dissection of Bfl-1, a Bcl-2 homolog: anti-apoptosis, oncogene-cooperation and cell proliferation activities. Oncogene (1998) 1.17
Structural determinants present in the C-terminal binding protein binding site of adenovirus early region 1A proteins. J Biol Chem (1998) 1.17
Association of class I histone deacetylases with transcriptional corepressor CtBP. FEBS Lett (2003) 1.16
Critical requirement of BAX for manifestation of apoptosis induced by multiple stimuli in human epithelial cancer cells. Cancer Res (2002) 1.16
Tumour antigen specificity of a DNA-binding protein from cells infected with adenovirus 2. Nature (1975) 1.16
Functional substitution of the basic domain of the HIV-1 trans-activator, Tat, with the basic domain of the functionally heterologous Rev. Virology (1990) 1.15
Comparison of antibody-dependent cellular cytotoxicity and complement-dependent antibody lysis of herpes simplex virus-infected cells as methods of detecting antiviral antibodies in human sera. J Clin Microbiol (1977) 1.15
Genetic identification of adenovirus type 5 genes that influence viral spread. J Virol (2006) 1.14
Functional domains of the HIV-1 rev gene required for trans-regulation and subcellular localization. Virology (1990) 1.13
Modulation of mitochondrial Ca(2+) homeostasis by Bcl-2. J Biol Chem (1999) 1.12
bfl-1, a bcl-2 homologue, suppresses p53-induced apoptosis and exhibits potent cooperative transforming activity. Cancer Res (1996) 1.11
mRNA from the transforming segment of the adenovirus 2 genome in productively infected and transformed cells. J Virol (1976) 1.11
Unmasking of a proliferation-restraining activity of the anti-apoptosis protein EBV BHRF1. Oncogene (1996) 1.10
BNIP3alpha: a human homolog of mitochondrial proapoptotic protein BNIP3. Cancer Res (1999) 1.09
Phosphorylation of the pro-apoptotic protein BIK: mapping of phosphorylation sites and effect on apoptosis. J Biol Chem (2000) 1.08
Requirement of a phage-induced 5'-exonuclease for the expression of late genes of bacteriophage T5. Proc Natl Acad Sci U S A (1973) 1.08
DNA polymerase from maize seedlings. Biochim Biophys Acta (1970) 1.06
Proteasomes modulate balance among proapoptotic and antiapoptotic Bcl-2 family members and compromise functioning of the electron transport chain in leukemic cells. J Immunol (2001) 1.03
The pro-apoptotic protein, Bik, exhibits potent antitumor activity that is dependent on its BH3 domain. Mol Cancer Ther (2001) 1.01
Adenovirus cyt+ locus, which controls cell transformation and tumorigenicity, is an allele of lp+ locus, which codes for a 19-kilodalton tumor antigen. J Virol (1984) 1.01
Colorimetric determination of patulin produced by Penicillium patulum. J Assoc Off Anal Chem (1982) 1.00
Deletion of a nonconserved region of Bcl-2 confers a novel gain of function: suppression of apoptosis with concomitant cell proliferation. Cancer Res (1996) 0.99
Stereotaxic intrastriatal implantation of human retinal pigment epithelial (hRPE) cells attached to gelatin microcarriers: a potential new cell therapy for Parkinson's disease. J Neural Transm Suppl (2003) 0.98
Dual role of gene D5 in the development of bacteriophage T5. Nature (1974) 0.98
Evaluation of a novel solubilized formulation of ibuprofen in the treatment of migraine headache: a randomized, double-blind, placebo-controlled, dose-ranging study. Cephalalgia (2000) 0.97
Functional dissection of the pro-apoptotic protein Bik. Heterodimerization with anti-apoptosis proteins is insufficient for induction of cell death. J Biol Chem (1997) 0.97
Adenovirus type 5 E1A and E6 proteins of low-risk cutaneous beta-human papillomaviruses suppress cell transformation through interaction with FOXK1/K2 transcription factors. J Virol (2010) 0.97
Activation of the adenovirus 2 protein IX promoter by DNA replication in a transient expression assay. Nucleic Acids Res (1987) 0.97
The carboxy-terminal transcription enhancement region of the human spumaretrovirus transactivator contains discrete determinants of the activator function. J Virol (1993) 0.97
Hinf family: a novel repeated DNA family of the human genome. Nature (1983) 0.96
Transforming genes among three different oncogenic subgroups of human adenoviruses have similar replicative functions. J Virol (1981) 0.95
Silencing of human immunodeficiency virus long terminal repeat expression by an adenovirus E1a mutant. Proc Natl Acad Sci U S A (1990) 0.95
Bak functionally complements for loss of Bax during p14ARF-induced mitochondrial apoptosis in human cancer cells. Oncogene (2006) 0.95
Regulation of apoptosis by a Caenorhabditis elegans BNIP3 homolog. Oncogene (1998) 0.94
Regulation of expression of late genes of bacteriophage T5. J Virol (1974) 0.94
Changes in C-terminal binding protein 2 (CtBP2) corepressor complex induced by E1A and modulation of E1A transcriptional activity by CtBP2. J Biol Chem (2006) 0.94
Immortalization of rat embryo fibroblasts by an adenovirus 2 mutant expressing a single functional E1a protein. J Virol (1985) 0.94